RNS Number : 2825E
Cambridge Cognition Holdings PLC
28 June 2023
 

Cambridge Cognition Holdings Plc

("Cambridge Cognition" or the "Company")


Result of AGM

 

Cambridge Cognition, which develops and markets digital solutions to assess brain health, held its Annual General Meeting ("AGM") earlier today at the registered office of the Company; Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU and announces that all resolutions put forward were duly passed.

 

Proxy votes were received in respect of approximately 48% of the Company's issued share capital and the votes cast were as follows:

 

Resolution

For

 

Against

 

Withheld

1 - to approve the 2022 report and accounts

16,768,921

100.00%

0

0.00%

0

2 - to reappoint the auditors

16,756,354

100.00%

0

0.00%

12,567

3 - to authorise the directors to set the auditors remuneration

16,768,921

100.00%

0

0.00%

0

4 - to re-elect Debra Leeves as a director

14,530,445

86.69%

2,231,350

13.31%

7,126

5 - to re-elect Stephen Symonds as a director

16,761,795

100.00%

0

0.00%

7,126

6 - authority to allot shares

13,216,411

78.83%

3,549,010

21.17%

3,500

7 - disapplication of pre-emption rights

12,976,508

77.63%

3,738,913

22.37%

53,500

 

 

Enquiries

 

Cambridge Cognition Holdings plc

Matthew Stork, Chief Executive Officer

Stephen Symonds, Chief Financial Officer

www.cambridgecognition.com

Tel: 01223 810 700

 

Panmure Gordon (UK) Limited (NOMAD and Joint Broker)

Freddy Crossley / Emma Earl / Mark Rogers

Rupert Dearden

Tel: 020 7220 0500

(Corporate Advisory)

(Corporate Broking)

Dowgate Capital Limited (Joint Broker)

David Poutney / James Serjeant

Tel: 020 3903 7715

(Corporate Broking)

IFC Advisory Ltd (Financial PR and IR)

Tim Metcalfe / Graham Herring / Zach Cohen

Tel: 020 3934 6630

cog@investor-focus.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGNKFBBPBKDPAB